Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

NASDAQ:LNTH

Overview | Financials
Company Name Lantheus Holdings, Inc.
Symbol LNTH
Currency USD
Price 101.1
Market Cap 6,922,984,260
Dividend Yield 0%
52-week-range 56.44 - 126.89
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Related Stocks

Premier, Inc. logo

Premier, Inc.

PINC

18.16 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

324.95 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

125.4 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

24.66 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

19.17 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

143.45 USD

Alkermes plc logo

Alkermes plc

ALKS

34.03 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

36.12 USD

Financials

Numbers are in millions USD

Numbers are in millions USD